Podcasts about urologic

Urologic oncologist Dr. Peter Carroll presents the latest research on active surveillance as a preferred approach for managing low-risk prostate cancer and selected cases of intermediate-risk disease. Drawing from two decades of UCSF data, he explains how long-term outcomes support the safety and effectiveness of delaying treatment for carefully monitored patients. Carroll emphasizes that surveillance decisions should be guided by MRI imaging, PSA density, cancer volume, histologic subtype, and genomic testing. He notes that while many men experience gradual changes over time, only a small percentage require immediate treatment. Carroll also discusses innovations such as AI-assisted pathology and risk profiling to reduce unnecessary procedures. His data-driven approach offers patients a personalized path that preserves quality of life without compromising outcomes. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40801]

Urologic oncologist Dr. Peter Carroll presents the latest research on active surveillance as a preferred approach for managing low-risk prostate cancer and selected cases of intermediate-risk disease. Drawing from two decades of UCSF data, he explains how long-term outcomes support the safety and effectiveness of delaying treatment for carefully monitored patients. Carroll emphasizes that surveillance decisions should be guided by MRI imaging, PSA density, cancer volume, histologic subtype, and genomic testing. He notes that while many men experience gradual changes over time, only a small percentage require immediate treatment. Carroll also discusses innovations such as AI-assisted pathology and risk profiling to reduce unnecessary procedures. His data-driven approach offers patients a personalized path that preserves quality of life without compromising outcomes. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40801]

Urologic oncologist Dr. Peter Carroll presents the latest research on active surveillance as a preferred approach for managing low-risk prostate cancer and selected cases of intermediate-risk disease. Drawing from two decades of UCSF data, he explains how long-term outcomes support the safety and effectiveness of delaying treatment for carefully monitored patients. Carroll emphasizes that surveillance decisions should be guided by MRI imaging, PSA density, cancer volume, histologic subtype, and genomic testing. He notes that while many men experience gradual changes over time, only a small percentage require immediate treatment. Carroll also discusses innovations such as AI-assisted pathology and risk profiling to reduce unnecessary procedures. His data-driven approach offers patients a personalized path that preserves quality of life without compromising outcomes. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40801]

Urologic oncologist Dr. Peter Carroll presents the latest research on active surveillance as a preferred approach for managing low-risk prostate cancer and selected cases of intermediate-risk disease. Drawing from two decades of UCSF data, he explains how long-term outcomes support the safety and effectiveness of delaying treatment for carefully monitored patients. Carroll emphasizes that surveillance decisions should be guided by MRI imaging, PSA density, cancer volume, histologic subtype, and genomic testing. He notes that while many men experience gradual changes over time, only a small percentage require immediate treatment. Carroll also discusses innovations such as AI-assisted pathology and risk profiling to reduce unnecessary procedures. His data-driven approach offers patients a personalized path that preserves quality of life without compromising outcomes. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40801]

Urologic oncologist Dr. Peter Carroll presents the latest research on active surveillance as a preferred approach for managing low-risk prostate cancer and selected cases of intermediate-risk disease. Drawing from two decades of UCSF data, he explains how long-term outcomes support the safety and effectiveness of delaying treatment for carefully monitored patients. Carroll emphasizes that surveillance decisions should be guided by MRI imaging, PSA density, cancer volume, histologic subtype, and genomic testing. He notes that while many men experience gradual changes over time, only a small percentage require immediate treatment. Carroll also discusses innovations such as AI-assisted pathology and risk profiling to reduce unnecessary procedures. His data-driven approach offers patients a personalized path that preserves quality of life without compromising outcomes. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40801]

Send us a textUrologist Dr. Dave Ludlow practices all aspects of general urology in Las Vegas, Nevada including minimally invasive and robotic techniques to treat urologic cancers, BPH (Benign Prostatic Hyperplasia), and kidney stones. He has published research articles and presented at multiple national conferences. Dr. Ludlow received his undergraduate degree at Brigham Young University, medical degree at University of Utah, and completed his urology residency at The Ohio State University with a focus on robotic and minimally invasive surgery.Dr. Ludlow is married and has 4 daughters with whom he loves spending time. He is a huge fan of sports, both watching and playing them; he currently is an avid golfer. In the past, he also competed in multiple endurance races including ultramarathons and the Boston Marathon. Dr. Ludlow spent multiple years abroad including 2 years in Taiwan and speaks Mandarin Chinese.

In this episode, Kevin and Dr. Wolf dive deep into the under-discussed but critically important world of renal and urologic emergencies. From the agony of kidney stones to the subtleties of urinary retention.  They discuss the dangers of delayed diagnosis, unpack key presentations, triage considerations, and red flags that emergency nurses must recognize. Urine color chart Click here https://www.medicalnewstoday.com/articles/urine-color-chart  Follow us on: Facebook: https://www.facebook.com/Art-of-Emergency-Nursing-276898616569046/  YouTube: https://www.youtube.com/channel/UCJTnz4phtCTjojTIDJo2afA?view_as=subscriber  Twitter: @AoenPodcast Instagram: https://www.instagram.com/artofemergencynursing/  To support the show: Leave an honest review on iTunes. Your ratings and reviews greatly contribute to the success of the podcast, and I appreciate each and every one of them. Subscribe on Apple Podcasts, Google Podcasts, or your preferred podcast platform to never miss an episode. Thank you for being a part of our AOEN community!

What if the key to better cancer outcomes lies not just in surgery or chemotherapy, but also in mindfulness, movement, and diet? In this episode of the BackTable Tumor Board, host Dr. Aditya Bagrodia interviews urologic oncologist Dr. Viraj Master, Professor of Urology at Emory University, about his role in developing the integrative oncology and survivorship service line at Winship Cancer Institute. --- This podcast is supported by: Ferring Pharmaceuticals https://ad.doubleclick.net/ddm/trackclk/N2165306.5658203BACKTABLE/B33008413.420220578;dc_trk_aid=612466359;dc_trk_cid=234162109;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;gdpr=${GDPR};gdpr_consent=${GDPR_CONSENT_755};gpp=${GPP_STRING_755};gpp_sid=${GPP_SID};ltd=;dc_tdv=1 --- SYNPOSIS They discuss the evidence-based use of complementary therapies alongside conventional cancer treatments, touching on various integrative methods including diet, exercise, mindfulness, acupuncture, yoga, and supplements. Dr. Master emphasizes the importance of physicians being open to these practices and understanding their potential benefits for improving patient outcomes and quality of life, even in highly acute cases like muscle-invasive bladder cancer. The conversation covers the importance of honesty and understanding across patient journeys–from initial diagnosis to survivorship–highlighting the value of holistic approaches in cancer care. ---TIMESTAMPS00:00 - Integrative Oncology: Definitions and Basics06:28 - Exercise and Its Impact on Cancer Treatment08:12 - Physician Perspectives on Complementary Medicine20:58 - Acupuncture and Acupressure in Cancer Care25:28 - Practical Implementation of Integrative Approaches31:30 - Supplements and Immuno Nutrition36:25 - Cannabis, CBD, and Ayurveda in Cancer Care44:39 - Conclusion and Final Thoughts --- RESOURCES Society of Urologic Oncologyhttps://suonet.org/home.aspx

How can pediatric and adult urologists team up to tackle complex cancer cases? In this episode of the BackTable Urology, host Dr. Amanda Buchanan, Division Chief of Pediatric Urology at the University of Kentucky, is joined by her colleagues Dr. Patrick Hensley, an adult urologic oncologist, and Dave Rodeberg, Division Chief of Pediatric Surgery. Their discussion centers around the importance of professional collaboration in urologic oncology care in order to improve patient outcomes.---SYNPOSISThe urologists discuss topics such as the experiences and benefits of interdisciplinary collaboration in complex cases and the role of pediatric urologists in treating adolescent and young adult patients. They also provide insights into the Children's Oncology Group (COG) studies and their intersections with adult oncology research. The episode concludes with practical advice for other institutions aiming to improve collaborative efforts between pediatric and adult urology departments.---TIMESTAMPS00:00 - Introduction02:35 - Challenges and Lessons in Multidisciplinary Collaboration08:24 - Pediatric vs. Adult Urologic Oncology11:07- Clinical Trials and Research Collaborations12:49 - Navigating Oncology Groups for Children and Adults19:06 - Collaborative Models in Kidney Cancer Care22:18 - Benefits and Challenges of Collaboration35:24 - Final Thoughts and Recommendations---RESOURCESSociety of Urologic Oncology:https://suonet.org/home.aspxChildren's Oncology Grouphttps://www.childrensoncologygroup.org/

Advancing Urologic Cancer Treatment with Cutting-Edge Technology with guest Dr. Preston Sprenkle May 18, 2025 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

AUA2025: PARP-Inhibitor Combination Treatments for the Urologic Care Team CME Available: https://auau.auanet.org/node/42822 At the conclusion of this CME activity, participants will be able to: 1. Apply the mechanism of action of PARP inhibitors and the rationale for using them in patients with advanced prostate cancer. 2. Recognize the role and importance of genetic testing in patients with mCRPC and the implications of germline mutations on response to therapy. 3. Identify best practices and utilize available guidelines for patients with mCRPC to optimize treatment success and oncologic outcomes. 4. Recognize when to use PARP inhibitors as monotherapy, the rationale and indications for combination therapy, and appropriate treatment sequencing. 5. Successfully counsel patients on the possible adverse events associated with PARP inhibitor therapies alone or in combination. ACKOWLEDGEMENTS Support provided by independent educational grants from: AstraZeneca Merck & Co., Inc.

How does the microbiome affect urologic health, and what role does it play in urinary tract infections (UTIs)? In this episode of BackTable Urology, Dr. Lennie Ackerman from UCLA joins host Dr. Suzette Sutherland to discuss the bladder microbiome and innovative methods for detecting UTIs. --- SYNPOSIS Dr. Ackerman and Dr. Sutherland talk through the challenges of diagnosing chronic UTI symptoms, the limitations of standard urine cultures, and the role of new, enhanced culture methods and molecular diagnostics. They emphasize the importance of clinical judgment, the potential misuse of antibiotics, and the need for a long-term approach to managing urinary symptoms while maintaining a healthy microbiome. --- TIMESTAMPS 00:00 - Introduction 01:58 - The Bladder Microbiome 05:44 - Challenges in Diagnosing UTIs 16:36 - Enhanced Quantitative Urine Culture 21:30 - Molecular Diagnostic Approaches 34:01 - Chronic UTIs and Long-Term Management 46:10 - Conclusion

The M.H. Mohseni Institute of Urologic Sciences has been launched within the Vancouver Coastal Health Research Institute, signifying a major milestone in advancing the diagnosis, treatment, and prevention of urologic diseases. Guest: Dr. Martin Gleave - Executive Director of the M. H. Mohseni Institute of Urologic Science Learn more about your ad choices. Visit megaphone.fm/adchoices

We discuss some of the main urologic goals for our pediatric patients with spina bifida. In addition to different treatment options and management considerations, we address the importance of multidisciplinary care.

Dr. Rachel S. Rubin is a board certified urologist with fellowship training in sexual medicine. She is an assistant clinical professor in urology at Georgetown University and owns her own practice in Washington DC. Dr. Rubin provides comprehensive care to all genders. She treats issues such as pelvic pain, menopause, erectile dysfunction, and low libido. Dr. Rubin is the director at large and former education chair for the International Society for the Study of Women's Sexual Health (ISSWSH) and an associate editor for the journal Sexual Medicine Reviews. Her work has been featured in the NYT, NPR and PBS. She was named a Washingtonian Top Doctor in 2019-2023.She has co-authored several publications on Genitourinary Syndrome ofMenopause (GSM) including:Houston CG, Azar WS, Huang SS, Rubin R, Dorris CS, Sussman RD. A Cost Savings Analysis of Topical Estrogen Therapy in Urinary Tract Infection Prevention Among Postmenopausal Women. Urology Practice. 2024 Mar 1; 11(2):257-266.https://doi.org/10.1097/UPJ.0000000000000513Wasserman MC and Rubin RS. Urologic view in the management of genitourinary syndrome of menopause. Climacteric. 2023 Apr 27;1-7. doi: 10.1080/13697137.2023.2202811. Epub aheadof print. PMID: 37104711.To learn more about Dr. Rachel Rubin MD, check out: https://www.rachelrubinmd.com/Or follow her on Instagram @drrachelrubinTo Follow US check out: Heather- www.theshowcenter.comJackie- https://www.mymonarchhealthco.comThe podcast- @justaskhiveHeather- @showcenterdrqJackie- @jackiep_gynnpThe course is live and available at:the-hive8.teachable.com

Our guests are Dr. Kristen Scarpato, a urologic oncologist at Vanderbilt University Medical Center, and Dr. Heather Honoré Goltz, a professor of social work at the University of Houston Downtown and a bladder cancer caregiver. The goal of this podcast is to give support and guidance to urologic cancer patients, their loved ones and their friends. Dr. Scarpato and Dr. Goltz talk about the psychosocial and emotional impact of a urologic cancer and review tips to help with the well-being and care of both patients and caregivers. Short on time? Use the below timestamps to jump to any topic section: 01:18 - Introduction 04:39 - Stages of urologic cancer journey 13:01 - Cancer treatment and the impact of family, work and way of life 19:28 - Coping methods and self-care tips for patients and caregivers 26:46 - Impacts of money on emotional and mental health 31:41 - Things that are not talked about during healthcare visit 34:17 - Final thoughts Funding and support provided by Astellas and Pfizer Oncology. For more information, please visit www.UrologyHealth.org and don't forget to subscribe to our free digital magazine, UrologyHealth extra® at www.urologyhealth.org/uhe. **** September 25, 2024

September is Prostate Cancer Awareness month. We welcome Dr. Jonah Marshall of St. Peter's Health Partners. Dr. Marshall specializes in urologic oncology, nerve-sparing prostate surgery and complex kidney surgery. He focuses both on cancer control and overall quality of life. Ray Graf hosts.

Today's podcast episode is part of the “Voices” series and is brought to you by the Diversity, Equity & Inclusion Committee. Join Dr. Lourdes Guerrios Rivera, urologic surgeon at the San Juan VA Medical Center and Assistant Professor of Surgery at the University of Puerto Rico as she talks with urologist, life coach and the founder of Physician Coach Support, Dr. Diana Londoño, on the increasing disability of the Latinas in the urologic field, as well as how important it is to take care of yourself.

This week, Jonathan is joined by Neal Shore, Medical Director at Carolina Urologic Research Center and Chief Medical Officer of Surgical Oncology and Urology at GenesisCare USA. In an enlightening conversation, they discuss the latest advancements in the field of urologic oncology and the wonderment of medicine.   Timestamps:    (00:00)-Introduction   (03:08)-What initially drew Neal to urologic cancers (05:44)-His most significant research advancements (12:30)-The privileges of medicine   (18:45)-Changes in the field (23:30)-Current guidance on the use of PSA to screen for prostate cancer (28:20)-How can we drive greater awareness of men's health issues? (33:40)-The robotic approach to prostate cancer (36:23)-Targeted alpha therapy (42:10)-Exciting innovations in urologic oncology (45:50)-Values in patient care (50:55)-Neal's three magic wishes

Dr. Sean Kern is urologic oncologist in the Murtha Cancer Center and Associate Professor of Surgery at the Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD. He is the founding Director of the military's Testicular cancer Enterprise for Survivorship, Treatment, and Investigational Sciences “TESTIS” Program and the Program Director of the Walter Reed Urology Residency. Dr. Kern shares his experience going from testicular cancer provider to testicular cancer patient after completing his fellowship at Indiana University, plus information about the military's TESTIS program and how it can help those diagnosed with the most common cancer in active duty men. This information provided is expressly the views of the author and does not imply or constitute Department of Defense or US Government endorsement. Sponsored by Dee's Nuts. Use code "nutcheck" at checkout on https://grabdeesnuts.com Want to be a guest? Apply here: ⁠https://www.testicularcancerawarenessfoundation.org/it-takes-balls-submissions⁠ Follow Testicular Cancer Awareness Foundation: ⁠https://www.testescancer.org https://www.twitter.com/testescancer⁠ ⁠https://www.instagram.com/testescancer https://www.facebook.com/tca.org/⁠ Connect with Dr. Kern: https://www.usuhs.edu/profile/sean-kern-md Follow Steven Crocker: https://www.twitter.com/stevencrocker https://www.instagram.com/stevencrocker https://www.facebook.com/steven.crocker2 Theme song: No Time Like Now - Tom Willner www.tomwillner.com

UN PODCAST PENTRU BĂRBAȚI, DAR ȘI PENTRU FEMEI: SĂNĂTATEA UROLOGICĂ CU CONF. DR. MARCIAN MANU #164

Best prevention tactics, diagnosis, and treatment options for urologic cancers—prostate, bladder, kidney, testicular.

Best prevention tactics, diagnosis, and treatment options for urologic cancers—prostate, bladder, kidney, testicular.

In this episode of our podcast, we welcome Dr. Robert Santa-Cruz, a fellowship-trained and board-certified Urologic surgeon, to discuss the groundbreaking daVinci SP Robot and its transformative impact on urological surgery.Whether you are a patient facing a urological procedure, a healthcare professional interested in the latest surgical advancements, or simply curious about the future of medicine, this episode is not to be missed. Hosted on Acast. See acast.com/privacy for more information.

Residents of the Lancaster and Chester counties don't need to travel far from home to receive state-of-the-art surgical care. Aravind Viswanathan, MD, a urologist and director for robotic surgery at MUSC Health Lancaster Division, discusses the range of urologic oncology and other surgical options offered, including the da Vinci robotic surgical system, a technology that offers shorter hospital stays and faster recovery for patients.

In 'Episode 4' of the special podcast series on "Uro-oncologic surgery driven by new technologies", Prof. Ricardo Autorino (IT) talks to expert Assoc. Prof. Giovanni Enrico Cacciamani (US) about Artificial intelligence application for urologic cancer detection and classification.Artificial Intelligence (AI) has revolutionised urologic cancer detection by leveraging principles from computer science, machine learning and deep learning. In this context, AI serves as a powerful tool to improve the accuracy and efficiency of cancer diagnosis and treatment.Assoc. Prof. Cacciamani shares his knowledge how computer science forms the foundation of AI algorithms, enabling the processing and analysis of vast datasets, including medical images and patient records. Machine learning techniques, a subset of AI, are applied to these datasets to create predictive models that can identify patterns and anomalies within patient data. Deep learning, a specialised branch of machine learning, excels in image recognition tasks and has been instrumental in the interpretation of medical images like CT scans, MRI scans, and histopathological slides.By implementing AI in urologic cancer detection, healthcare professionals can achieve faster and more accurate diagnosis, early cancer detection, and personalised treatment recommendations. AI systems can assist in the identification of tumours, tracking their growth over time, and predicting patient outcomes. This integration of AI technologies enhances the quality of patient care, potentially leading to better survival rates and improved overall well-being for individuals with urologic cancers.This podcast was produced in collaboration with the YAU Urotechnology group.

Sounak Gupta, M.B.B.S., Ph.D., explains how Mayo Clinic Laboratories' urologic panels efficiently inform prognosis and individualized cancer treatment. The carefully curated panels fill the void between single gene assays and large NGS panels.(00:32) Could you provide our listeners with a little bit about yourself and your background, please? (01:35) Could you give us a brief overview of the newly developed urologic assays? (03:51) Can you talk a little bit more about what patients should have this testing? (07:24) Can you talk in more detail about the MayoComplete bladder and prostate panel? (11:33) How are these results used in patient care? (16:10) Is there anything else you would like to add?

In this podcast, Dr Williams speaks with Dr Bill Jaffe, urologist at Penn, to get practical guidance on how to tackle common male urologic concerns in primary care, including BPH, overactive bladder, ED, and low testosterone.

This week's episode dives into racial disparities in healthcare and the field of urology, with a focus on prostate and bladder cancer. Jonathan and Samuel Washington, University of California San Francisco (UCSF), USA, discuss equality and equity in healthcare, uncovering how racial disparities affect the diagnosis and treatment of urological tumours, particularly in African American men. The pair also speak about which groups are more at risk of experiencing adverse outcomes, the changes needed to ensure better care is available to these patients, and how racial disparities affect medical education. Use the following timestamps to navigate the topics discussed in this episode: (00:00)-Introduction (01:58)-Inspiration which led Washington to work in urologic oncology (02:42)-“Urologic personality” traits (04:01)-Machine-learning algorithms in estimating occurrence of lymph node cancer (06:26)-Dietary and lifestyle factors influencing patient outcomes (08:06)-Healthcare disparities in treating genitourinary diseases (09:45)-Changes needed to make outcomes equivalent for patients of different races (12:52)-Societal and political factors interacting with healthcare (15:04)-Socioeconomic factors impacting healthcare use after bladder removal (16:59)-Equity and equality in healthcare: health literacy and shared decision-making (18:42)-Tailoring patient communications in prostate cancer screening (20:00)-Partner-supported treatment decisions (21:03)-Racial and ethnic differences in medical student training (22:23)-Three wishes for the future of healthcare

The Use of Robotics/Minimally Invasive Surgery for Urologic Cancers with guest Dr. Joseph Brito May 7, 2023 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

The Use of Robotics/Minimally Invasive Surgery for Urologic Cancers with guest Dr. Joseph Brito May 7, 2023 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

During the past decade “the number of new drugs and the pathways that we're targeting has expanded so much; it's a very exciting time,” said Eric Singer, MD, a kidney cancer specialist and the new division chief for urologic oncology at the James. In this episode, Singer discusses how and why he got into medicine and oncology, why he uprooted from New Jersey to come to Ohio State, and some of the many advances in treating urologic cancers. A new clinical trial for kidney cancer patients introduces targeted therapy drugs and immunotherapy drugs to patients prior to surgery. Another clinical trial utilizes different combinations of drugs; and another clinical trial uses “adjuvant” therapy after surgery. “It's the idea that after surgery, even though there is no evidence of cancer, we give the drugs to reduce the chance of it coming back [for high-risk patients],” Singer explained. Urologic cancers include kidney, cladder, prostate, testicular, penial and adrenal cancers. The James division of urologic oncology is growing, and Singer is actively recruiting new surgeons. “I look for someone with incredible passion and a commitment to being a great surgeon, someone who is always thinking how does this benefit the patient,” he said. Singer also talked about how cancer has impacted his family, including his sister, who passed away from ovarian cancer. “Seeing her go through it … was heartbreaking and also so inspiring,” he said, adding her journey has inspired him to go above and beyond for his patients.

Urologic surgeon and sexual health specialist, Dr. Arthur Burnett, from Johns Hopkins Medicine joins our show this week. Dr. Burnett discusses improving sexual health and overall wellness.  Dr. Burnett is the author of a newly published book "The Manhood Rx", which you can learn more about here. The Erectile Dysfunction Radio Podcast is dedicated to educating and empowering all sexual health patients to address erectile dysfunction or any other sexual dysfunction or sexual health issue. It also serves to improve confidence and enhance the satisfaction in the relationships of our listeners. This podcast is hosted by certified sex therapist, Mark Goldberg, LCMFT, CST. Learn to think differently about erections to resolve your ED struggles with our "Beyond the Little Blue Pill" eCourse: https://erectioniq.com/course    For more free erectile dysfunction education and resources, please visit: https://erectioniq.com/       Mark Goldberg helps men resolve erectile dysfunction. He offers individual, one-on-one services to men throughout the world through a secure, telehealth platform. It's 100% confidential. You can visit the Center for Intimacy, Connection and Change website to schedule a free consultation: https://centericc.com/  

In this episode, I have a conversation with Dr. Fenwa Milhouse. She's a board-certified, fellowship-trained urologist and a black woman. She trained at the University of Chicago for urology residency.  After that, she completed her fellowship in female pelvic medicine and reconstructive surgery. She is passionate about introducing the public to the world of urology, and urology as it pertains to women's health, mentoring underrepresented minorities, and diversity and inclusivity in the workplace. She says that women should embrace their private parts. You don't have to just live with urinary incontinence. And women deserve to have orgasms too!What is a urologistLeaky bladder, bladder pain & UTIsThe potential risk of vaginal steamsOrgasms & sexual healthand moreConnect with Tamikawww.tamikamctier.comhttps://www.instagram.com/_tamikamctier/Connect with Dr. Fenwawww.yourfavoriteurologist.comhttps://www.instagram.com/drmilhouse/

Complex urologic infections are a heterogeneous group of underlying conditions. These patients have upper urinary tract infections (UTIs) and structural or functional abnormalities that reduce the efficacy of antimicrobial therapy. They are at greater risk for treatment failure and morbidity, such as bacteremia and sepsis, perinephric abscess, renal deterioration and emphysematous pyelonephritis. While there are general management principles that can be applied to most patients with complex urologic infections, effective treatment requires a comprehensive, personalized approach to improve patient outcomes.In pursuit of this goal, the Northwestern Medicine Complex Urologic Infectious Diseases Clinic is the first of its kind in the country. The clinic will provide a multidisciplinary, coordinated approach to care for affected patients. In this Better Edge podcast episode, the clinic's founders – Anthony J. Schaeffer, MD, of the Northwestern Medicine Department of Urology, and Teresa R. Zembower, MD, and Janna L. Williams, MD, of the Northwestern Medicine Division of Infectious Diseases in the Department Medicine – introduce the new clinic and discuss their team's current projects and future directions.

Hear from renowned urologist John Libertino, MD about why patients choose Emerson Health Urology for routine and advanced care.

Operationalizing Checkpoint Inhibitors in Urologic Practice (2022) CME Available: https://auau.auanet.org/node/36084 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Discuss how to develop a structured approach for administering checkpoint inhibitors in urologic practice as part of a structured program. 2. Manage adverse events from checkpoint inhibitors 3. Identify practice implications of implementing a checkpoint inhibitor program

Controversies, Confusion, and the Future of Urologic Post-Operative Opioid Prescribing Reduction Strategies CME Available: https://auau.auanet.org/node/35160 Course Director: Jennifer Robles, MD, MPH Faculty: Chad Brummett, MD; Gregory Auffenberg, MD, MS; Hitya Abraham, MD; Kevan Sternberg, MD After participating in this activity, learners will be able to: 1. Identify at least one non-pharmaceutical method they can practically implement to manage post-operative pain and reduce post-operative opioid prescribing. 2. Discuss multi-modal pain control and identify at least two non-opioid medications which can be used to manage post-operative pain and reduce post-operative opioid prescribing.

We are joined by Dr. Jonah Marshall of St. Peter's Health Partners. Dr. Marshall specializes in urologic oncology, nerve-sparing prostate surgery and complex kidney surgery. He focuses both on cancer control and overall quality of life. The number to call with your question is 800-348-2551. Ray Graf hosts.

Urologic oncologist, Dr. David Silver, joins the podcast this week to chat about several types of cancer that might impact a man's sexual function. This interview also covers the anxiety brought on by a cancer diagnosis and how to best navigate the psychological stress of the event. Dr. Silver is Chief of Urology and Director of the Prostate Center at Maimonides Medical Center in New York. The Erectile Dysfunction Radio Podcast is dedicated to educating and empowering men to address erectile dysfunction, improve confidence, and enhance the satisfaction in their relationships. This podcast is hosted by certified sex therapist, Mark Goldberg, LCMFT, CST. Learn to think differently about erections to resolve your ED struggles with our "Beyond the Little Blue Pill" eCourse: https://erectioniq.com/course          For more free erectile dysfunction education and resources, please visit: https://erectioniq.com/   Mark Goldberg helps men resolve erectile dysfunction. He offers individual, one-on-one services to men throughout the world through a secure, telehealth platform. It's 100% confidential. You can visit the Center for Intimacy, Connection and Change website to schedule a free consultation: https://centericc.com/     

Urologic oncologist in the Glickman Urological and Kidney Institute, Zeyad Schwen, MD joins the Cancer Advances podcast to discuss transperineal biopsy and advances in screening for prostate cancer. Listen as Dr. Schwen explains the benefits of the transperineal prostate biopsy technique and why with the use of better imaging, as well as reduced risks of infection, this technique is coming to the forefront.

Dr. Chamie is a unique and very wise man. His skill level to put together a Dream Team 12-hour double operation is both imaginative and miraculous as a surgeon and visionary. His thoughts on the intention of the surgery are spot on as I am living proof.  He is my Super Hero!Watch this episode on YouTube, our website, or on our LYM mobile app (available on iOS and Android)Support the show (https://www.buymeacoffee.com/leaveyourmark)

Stephanie Kielb MD and Mara Markzon discuss improving outcomes and discharge planning for complex urologic surgery. They share their approach to discharge planning for patients undergoing these complex urologic procedures, how this approach has improved patient flow and reduced hospital length of stay/time to discharge and how physicians can help facilitate the discharge planning process.

Mandi Buss LCSW, OSW-C discusses the importance of supportive care for urologic cancer patients. She talks about the Supportive Oncology Program at Northwestern Medicine – which provides tailored emotional and practical support for patients and families coping with the challenges of cancer diagnosis, treatment and recovery – and how supportive cancer care optimizes outcomes for patients.

In this episode we discuss robotic radical prostatectomy as a treatment option for prostate cancer. Over the last 20 years, robotic radical prostatectomy has become the gold standard for surgical management of prostate cancer.  While the concept of robotic surgery is exciting, it also leads to a lot of questions amongst men faced with a decision as to how to treat their prostate cancer.  How does the procedure actually work?  Is the surgery performed by a surgeon or by a robot?  What are the risks and side effects? Are all men good candidates for the procedure.  And, of course, how effectively does it cure prostate cancer?  To answer these questions we turned to Dr. Alexander Kutikov.  Dr. Kutikov is a Professor and Chief of Urology and Urologic Oncology at the Fox Chase Cancer Center. He is a board certified, academic urologic surgical oncologist who treats urologic tumors using minimally invasive (robotic / laparoscopic) and traditional surgical techniques. Dr. Kutikov received an MD from Harvard Medical School's Harvard-MIT Health Sciences and Technology Program in 2003. He then completed his Urologic residency training at the University of Pennsylvania in 2008 and finished a 2-year Society of Urologic Oncology fellowship at the Fox Chase Cancer Center in Philadelphia, USA. He has co-authored more than 170 original manuscripts in peer-reviewed journals and has published chapters in leading urologic textbooks as well as holding leadership positions both in the American College of Surgeons and the American Urological Association.

Shane Pearce is the Director of Urologic Oncology at Sacred Heart Hospital in Spokane, WA. He talks with us about advances in robotic surgery, immunotherapy, and why the Sears Tower isn't a reliable unit of measurement!

“Urology is a subspecialty,” says Khatiwoda. “It's a surgical subspecialty that focuses on the genital urinary systems and disorders of the genital urinary system. It's essentially how you pee, how your kidneys work, your bladder, prostate in men, and some urethra and vaginal disorders in women.”“My subspecialty is gynecology, and it's a blend of both urology and gynecology,” says Moyerbrailean. “Matter of fact, that's where it got its start. The two boards got together to make a discipline that just focuses on female pelvic floor disorders. In addition to problems with the bladder and the urethra, we also deal mostly with pelvic floor issues like prolapse, uterine prolapse, and bladder prolapse.”“I'm a general adult urologist,” Khatiwoda says. “I see men and women and practice general urology. Kidney stones are a big part of it. Urinary disorders or what we call voiding dysfunction are a part of it. Incontinence in women or leakage of urine is a big part of it.“When most people hear about urology, they usually think of men's health and men's issues. It's very nice to have someone who's female focused like Dr. Moyerbrailean. It brings a certain element to our practice that you don't always think about when you hear the word urology. In terms of practice philosophy, it's about providing something to the community that many may not even realize is available. Urology is a personal subspecialty. You're dealing with a lot of things that people aren't always very forthcoming about. At MSU Urology, we're here to provide excellent care to the community and provide urologic care that's at the top of the technological forefront. For me personally, it's about building relationships with people and helping them open up about something that's quite personal that they may be embarrassed to talk about otherwise.”What symptoms would someone experience that would lead them to seek out a urologist?“In general, we see men and women who have urinary issues,” says Khatiwoda. “Are you peeing too much? Are you not peeing enough? Are you leaking when you shouldn't be? Are you not able to empty when you should be? And we see anyone who sees blood in the urine, anyone with a history of kidney stones, and anyone who has infections more frequently than they should. And there are things that they may not be aware of that their primary doctor would figure out, like is there a growth somewhere in one of the genital urinary organs, the kidneys, the bladder, the penis, or the urethra?”“I don't treat men,” Moyerbrailean says. “My training was based in obstetrics and gynecology and branched out into urogynecology. But we also do similar treatments with women, especially women with overactive bladder. That's probably one of the biggest things we see and one of the areas that women tend not to want to come in to see the doctor about or are embarrassed to talk about. But it is so common. Up to 80 percent of women by the age 80 have an overactive bladder. They just feel like they have to go all the time. And a lot of times their friends are telling them that there's just nothing they can do about it. That's wrong. There are plenty of things that can be done that can actually help alleviate some of those symptoms. Where I differ from my urologic counterparts is I deal a lot more with pelvic floor problems, mostly the prolapse issues.“Some would say it's a result of childbirth. And most women are afraid to come in and have that treated figuring that surgery is the only thing that can be done when that's not accurate either. That's one of the big myths in this field, and there are things you could do that actually help alleviate those symptoms.”Say more about how you treat urologic disease. “Urology is unique in that while it's a surgical subspecialty, we actually do a lot of nonsurgical treatments,” continues Khatiwoda. “For most of the benign disorders - so obviously not cancer, but non-cancerous disorders - the first step is very basic and it's usually behavioral therapy. There are medications and then typically the last step tends to be surgery. There are surgical treatments for almost every disorder that a patient might come to see us for. We tend to start very basic and then move up from there.”“Sometimes people think all we want to do is perform surgery,” Moyerbrailean adds. “The majority of the time we're not doing surgery; we're actually treating the person first and finding out what exactly they need. What are their goals? We figure that out at the very first visit. Where are they in their care and what do they want? We give them the options and let them choose.”Are there particular challenges in treating urologic diseases? And is there research or new treatments on the horizon you're excited about?“Sometimes patients come to us with an expectation that we can't always meet,” Khatiwoda continues. “Let's say you have someone who has had a problem for 20 years and they finally can come and see a urologist. We do get some patients who expect immediate and 100 percent change. It's almost impossible to take a problem that's been there for 20 years and fix it in 20 minutes. But the nice thing is, you don't have to see a urologist once in your life.“It's usually a lifelong relationship with your urologist. And there really is a certain trial and error that comes with a lot of the benign urology issues where you try something and if it doesn't work, then we reevaluate you in the clinic and then we try something else and ultimately look for a goal that improves your quality of life. You may never be how you were when you were 18 or 20, but we can certainly get you to a point where you're more comfortable and you're happier with your symptoms than you were when you came in.”“We treat on a bother-most system where we go after what bothers you the most and try to help you in that respect,” continues Moyerbrailean. “Some things we can't cure. We are trying, and there's always new research coming out. We're always talking about new things. But that's really where our challenge is. Some of our disorders are not curable, but they are certainly treatable. And we've got a lot of treatments to offer.”“I feel like there's always something new,” Khatiwoda says. “We really are living in an exciting time of medicine where there is always something new. And from a general urology standpoint, the way we look for cancers, especially prostate cancer in men, has really changed the game. First, it used to just be a doctor felt your prostate and if there was something abnormal, they did a biopsy. Then it was the PSA lab test. Now we're at a point where we can do MRIs of the prostate and really pinpoint specific areas that need to be biopsied. Even since I graduated residency in 2018, there has been a huge shift in how we look at men and men's health and prostate cancer. So, yes, it seems like there's always something new every day. And it's a very exciting time to be a urologist.”“Again, my specific focus is pelvic floor disorder,” says Moyerbrailean. “It's basically weakened tissue in the female pelvis. There's a lot of work being done now in stem cell research trying to figure out ways to improve the tissue quality. If we could improve tissue, then we would have a better chance at successfully fixing it or maybe preventing it all together.”Is urologic disease hereditary, environmental, or a combination? Can we avoid some or all of it with a healthier life?“It's definitely a combination,” says Khatiwoda. “There are some things that genetics can be blamed for. Kidney stones are one of those. But at the same time, if you have a genetic predilection but you also don't drink any water, your risk is way higher than if you're someone who is well hydrated. Genetics are big. So are your environmental factors and the decisions you make about your health.”“We go back and forth about that in the research world as far as the pelvic floor and whether or not that's something that's hereditary or not,” says Moyerbrailean. “We're still looking for answers in that respect. Smoking and occupations that are very strenuous are much more likely to lead to disorders. You can make a difference by changing your health and lifestyles.”Are there some facts about urology you'd like to reinforce or some myths you often hear that you'd like to dispel?“I have one that really gets my goat,” continues Khatiwoda. “It comes from anyone who has had a kidney stone and passed it on their own without seeing a urologist. They always come in and they say, ‘I have not had any calcium. I don't drink any milk. I gave up all dairy.' That is not a good thing to do. It's typically not calcium that's the problem. It's other things in your diet. I mentioned a lack of hydration. It's usually not drinking enough water or other food issues.“There are things called oxalates that are found in a variety of foods, even in foods we think are healthy, that can contribute to stone formation. The first thing I tell my patients, especially post-menopausal women who seem to get stones, is to make sure they get the amount of calcium that they need to get. That means the normal dietary recommendation because otherwise you're going to start having trouble with osteoporosis, and it's probably not going to make your stone risk any better. That is something that I think people don't have a great understanding of because they think stones are made of calcium. They decide to cut out all calcium. But that's usually not what you need to do to make your situation better.”“I think the biggest myth in my field is that surgery is the only possible option, and that's not true,” says Moyerbrailean. “As a matter of fact, we probably do nonsurgical therapy for eight out of every nine patients who come to us with some type of a pelvic floor disorder to give them adequate relief. One in five women actually in their lifetime will end up having surgery or some type of a treatment for either urinary incontinence or prolapse of some sort.”“If you're concerned about a problem with your bladder or you've got a problem with your bowels, seek out your family doctor and talk to them. If they're not comfortable taking care of you, MSU Urology is here. We can definitely take them on and that's what we do. We do it day in and day out. It's pretty straightforward for us and we do everything we can to make our patients comfortable.”MSU Today airs Sunday mornings at 9:00 on WKAR News/Talk and streams at WKAR.org. Find, rate, and subscribe to “MSU Today with Russ White” on Spotify, Apple Podcasts, and wherever you get your shows.

In this episode of the Maximus Podcast, Dr. Cam Interviews one of the medical advisors at Maximus, Dr. Matthew Coward. Dr. Coward is a professor of urology at UNC School of Medicine and an expert when it comes to men's health, men's reproductive health, Urology & Urologic surgery, Hormone Function & Hormone optimization. Learn more about testosterone, how it is mad in the body, and the new approach to increasing testosterone without taking steroids or synthetic T. Chapters 00:00 Intro 01:45 How Dr. Coward got into Urology 04:00 How he got his expertise in hormone function & endocrinology 08:10 Why did Dr. Coward become an advisor for Maximus 10:30 Everything you need to know about Testosterone and T levels 13:10 What may cause low testosterone in men 18:00 How to safely increase your Testosterone 21:20 Environmental disrupting factors to men's testosterone 26:30 Diet, Exercise & Sleep contribution to T Levels 29:30 Food and how it effects testosterone 34:10 Belly fat and obesity 36:00 The importance of health coaching and behavior change 37:20 The Maximus protocol and why its better for most men than TRT 41:30 Why Encomiphene is newer and better that Clomid 42:30 The benefits of optimizing their T 44:30 Why Enclomiphene is safe to take long term or stop using at any time 46:10 Does Enclomiphene cause hair loss 49:30 How covid-19 infections cause lower testosterone production 52:50 Outro

Emergency care providers regularly encounter urologic disease in the ED, often without the availability or assistance of a board-certified urologist. Common urologic clinical dilemmas in the emergency department include the management of acute urinary retention, nephrolithiasis, testicular (and ovarian) torsion. In this episode, we will review clinical conundrums related to each of the aforementioned urologic pathologies.Watch Dr. Tabatabai's presentation @ https://www.youtube.com/watch?v=1uFEhKU-Thc